BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/7/2022 8:29:04 AM | Browse: 318 | Download: 822
Publication Name World Journal of Gastroenterology
Manuscript ID 76760
Country Canada
2022-03-30 13:40
Peer-Review Started
2022-03-30 13:43
To Make the First Decision
Return for Revision
2022-06-10 19:45
2022-07-27 20:46
Second Decision
2022-08-17 03:19
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2022-08-17 18:51
Articles in Press
2022-08-17 18:51
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2022-08-30 20:16
Publish the Manuscript Online
2022-09-07 08:29
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright All the authors report no relevant conflicts of interest for this article.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Observational Study
Article Title Impact of adalimumab on disease burden in moderate-to-severe ulcerative colitis patients: The one-year, real-world UCanADA study
Manuscript Source Unsolicited Manuscript
All Author List Talat Bessissow, Geoffrey C Nguyen, Osman Tarabain, Laurent Peyrin-Biroulet, Nathalie Foucault, Kevin McHugh and Joannie Ruel
Author(s) ORCID Number
Talat Bessissow http://orcid.org/0000-0003-2610-1910
Geoffrey C Nguyen http://orcid.org/0000-0001-7083-7429
Laurent Peyrin-Biroulet http://orcid.org/0000-0003-2536-6618
Kevin McHugh http://orcid.org/0000-0001-9331-1614
Joannie Ruel http://orcid.org/0000-0001-6996-0120
Funding Agency and Grant Number
Corresponding Author Talat Bessissow, FRCP (C), MD, MSc, Associate Professor, Department of Medicine, McGill University Health Center, 1650 Avenue Cedar, Montreal H3G 1A4, Quebec, Canada. talat.bessissow@mcgill.ca
Key Words Disease burden; Patient-reported outcome; Depressive symptoms; Ulcerative colitis; Adalimumab; Real-world data
Core Tip In real-world at week 52, over 60% of patients with moderate-to-severe ulcerative colitis treated with adalimumab had their depressive symptoms improved, as well as their quality of life, fatigue symptoms, and work impairment. No new safety signals were detected.
Publish Date 2022-09-07 08:29
Citation Bessissow T, Nguyen GC, Tarabain O, Peyrin-Biroulet L, Foucault N, McHugh K, Ruel J. Impact of adalimumab on disease burden in moderate-to-severe ulcerative colitis patients: The one-year, real-world UCanADA study. World J Gastroenterol 2022; 28(34): 5058-5075
URL https://www.wjgnet.com/1007-9327/full/v28/i34/5058.htm
DOI https://dx.doi.org/10.3748/wjg.v28.i34.5058
Full Article (PDF) WJG-28-5058.pdf
Full Article (Word) WJG-28-5058.docx
STROBE Statement 76760-STROBE-Statement-revision.pdf
Manuscript File 76760_Auto_Edited-LM.docx
Answering Reviewers 76760-Answering reviewers.pdf
Audio Core Tip 76760-Audio core tip.m4a
Biostatistics Review Certificate 76760-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form 76760-Conflict-of-interest statement.pdf
Copyright License Agreement 76760-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s) 76760-Informed consent statement.pdf
Institutional Review Board Approval Form or Document 76760-Institutional review board statement.pdf
Supplementary Material 76760-Supplementary material.pdf
Peer-review Report 76760-Peer-review(s).pdf
Scientific Misconduct Check 76760-Bing-Fan JR-2.png
Scientific Editor Work List 76760-Scientific editor work list.pdf